High-intensity training for patients with spondyloarthritis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of high-intensity interval training (HIIT) on patients diagnosed with axial spondyloarthritis. It compares the physiological, inflammatory, and self-reported health outcomes of participants undergoing HIIT versus those receiving standard training. The research aims to enhance understanding of how HIIT can improve adherence to exercise and overall health in this patient population. By examining both short-term and long-term effects, the study seeks to provide tailored exercise recommendations for better self-management of the condition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Axial SpA (ICD10 diagnosis of M45, M46.0, M46.1, M46.8 and M46.9).
* Fulfilling recommendations for physical activity

Exclusion Criteria:

* Changed TNF and anti-inflammatory medication the previous three months
* Cardiovascular disease
* Comorbidities making high-intensity training inappropriate
* Performing high-intensity interval training on a regular basis

Where it's running

• Halmstad University
  Halmstad, Halland County, Sweden Recruiting

Study contacts

• Principal investigator: Haglund, Assoc. prof. — Dept. of Environmental and Biosciences, Halmstad University, Sweden
• Study coordinator: Emma Haglund, Assoc. prof.
• Email: emma.haglund@hh.se
• Phone: +46703838848

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Surface topography and spine damage in radiographic axial spondyloarthritis

  This study tests whether a radiation-free 3D surface topography method can reflect spine damage and sagittal balance in adults with radiographic axial spondyloarthritis.

  Recruiting Ankara Etlik City Hospital · Ankara, Yenimahalle · NCT07855393

• RENEW: a digital program to help people with axial spondyloarthritis manage energy and symptoms

  A web-based, peer-led program called RENEW is tested to see if people with axial spondyloarthritis can easily use it, like it, and benefit from it in managing fatigue and symptoms.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT07836374

• ExerciseRx app for people with axial spondyloarthritis

  A mobile app called ExerciseRx is tested to see if it helps people with axial spondyloarthritis exercise more regularly and feel better than usual care.

  Recruiting at 2 sites University of Washington · Seattle, Washington and 1 other locations · NCT07642622

• Carotid ultrasound to guide prevention of heart disease in inflammatory rheumatic diseases

  In people with inflammatory rheumatic diseases like RA, PsA, AxSpA, or SLE who are at modest cardiovascular risk, a carotid ultrasound test is used to see if they should start stronger lipid-lowering therapy to prevent heart problems.

  Recruiting at 7 sites Phase 4 Instituto de Investigación Marqués de Valdecilla · Alicante, Alicante and 16 other locations · NCT07611747

• Bimekizumab by IV infusion versus subcutaneous injection for adults with psoriatic arthritis or axial spondyloarthritis

  This trial tests whether bimekizumab given by intravenous (IV) infusion behaves the same in the body as the usual subcutaneous injection in adults with psoriatic arthritis or axial spondyloarthritis.

  Recruiting at 65 sites Phase 1 UCB Pharma · Peoria, Arizona and 64 other locations · NCT07290036

• Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases

  This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.

  Recruiting at 2 sites Phase 4 University of Sao Paulo General Hospital · São Paulo, São Paulo and 1 other locations · NCT07087912

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.